Mechanisms of vascular damage by systemic dissemination of the oral pathogen Porphyromonas gingivalis by Farrugia, C. et al.
This is a repository copy of Mechanisms of vascular damage by systemic dissemination of
the oral pathogen Porphyromonas gingivalis.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/164322/
Version: Published Version
Article:
Farrugia, C. orcid.org/0000-0003-1318-8885, Stafford, G.P., Potempa, J. et al. (4 more 
authors) (2020) Mechanisms of vascular damage by systemic dissemination of the oral 
pathogen Porphyromonas gingivalis. The FEBS Journal. ISSN 1742-464X 
https://doi.org/10.1111/febs.15486
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Mechanisms of vascular damage by systemic
dissemination of the oral pathogen Porphyromonas
gingivalis
Cher Farrugia1 , Graham P. Stafford1, Jan Potempa3,5, Robert N. Wilkinson2, Yan Chen4,
Craig Murdoch1 and Magdalena Widziolek1,3,6
1 School of Clinical Dentistry, University of Sheffield, UK
2 School of Life Sciences, Medical School, University of Nottingham, UK
3 Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krako´w, Poland
4 Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, UK
5 Department of Oral Immunity and Infectious Diseases, University of Louisville School of Dentistry, KY, USA
6 Department of Evolutionary Immunology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University,
Krako´w, Poland
Keywords
cardiovascular disease; Porphyromonas
gingivalis; endothelial cells; periodontal
disease; gingipain
Correspondence
C. Murdoch, Integrated Bioscience, School
of Clinical Dentistry, University of Sheffield,
Sheffield S10 2TA, UK
Tel: +44 114 2159367
E-mail: c.murdoch@sheffield.ac.uk
Cher Farrugia, Craig Murdoch and
Magdalena Widziolek contributed equally to
this work.
(Received 18 April 2020, revised 15 June
2020, accepted 14 July 2020)
doi:10.1111/febs.15486
Several studies have shown a clear association between periodontal disease
and increased risk of cardiovascular disease. Porphyromonas gingivalis (Pg),
a key oral pathogen, and its cell surface-expressed gingipains, induce
oedema in a zebrafish larvae infection model although the mechanism of
these vascular effects is unknown. Here, we aimed to determine whether
Pg-induced vascular damage is mediated by gingipains. In vitro, human
endothelial cells from different vascular beds were invaded by wild-type
(W83) but not gingipain-deficient (ΔK/R-ab) Pg. W83 infection resulted in
increased endothelial permeability as well as decreased cell surface abun-
dance of endothelial adhesion molecules PECAM-1 and VE-cadherin com-
pared to infection with ΔK/R-ab. In agreement, when transgenic zebrafish
larvae expressing fluorescently labelled PECAM-1 or VE-cadherin were sys-
temically infected with W83 or ΔK/R-ab, a significant reduction in adhe-
sion molecule fluorescence was observed specifically in endothelium
proximal to W83 bacteria through a gingipain-dependent mechanism. Fur-
thermore, this was associated with increased vascular permeability in vivo
when assessed by dextran leakage microangiography. These data are the
first to show that Pg directly mediates vascular damage in vivo by degrad-
ing PECAM-1 and VE-cadherin. Our data provide a molecular mechanism
by which Pg might contribute to cardiovascular disease.
Introduction
The effect of oral health on systemic disease is currently a
highly debated topic with increasing evidence indicating
that blood-borne oral microbes significantly contribute
to conditions such as cardiovascular disease (CVD) [1,2],
rheumatoid arthritis [3], diabetes [4] and Alzheimer’s
disease [5]. The association between periodontitis and
cardiovascular disease has been studied for the last three
decades and is now generally accepted in the field [6].
Periodontitis is a chronic multifactorial inflamma-
tory disease caused by the dysbiosis of indigenous
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microorganisms and characterised by the destruction
of tooth-supporting structures leading to tooth loss
[7,8]. Porphyromonas gingivalis (Pg), an oral anaerobic
microbe, is considered the keystone pathogen that pro-
motes the development of severe periodontitis by
favouring oral microbial dysbiosis and dysregulation
of the host immune response [9]. Pg resides in dental
plaque and produces several virulence factors that
enable this microbe to colonise the host, evade the
immune system and contribute to disease progression
and tissue destruction [9,10]. The predominant viru-
lence factors appear to be gingipains, cysteine pro-
teases with significant proteolytic activity [11].
The presence of oral bacteria has been detected in
peripheral blood following tooth extractions and even
regular oral hygiene procedures such as tooth brush-
ing, giving rise to a transient bacteraemia in healthy
individuals [12]. However, the likelihood of bacterial
entry to the circulation is greatly increased in patients
with chronic gingivitis or periodontitis where bacterial-
mediated loss of gingival epithelial integrity facilitates
bleeding, allowing pathogenic oral bacteria facile
movement from the periodontal pocket into the blood-
stream [13–15]. Indeed, oral microbiome profiling per-
formed on patients with atherosclerotic CVD
undergoing bypass surgery revealed that Pg was the
most abundant species found in nondiseased vascular
tissue [16]. Furthermore, Pg DNA was detected in car-
diac valves of patients with CVD and deep periodontal
pockets [17].
Pg is able to bind to and invade endothelial cells
cultured in vitro [18,19]. This microbial–host interac-
tion mediates increased gene expression of several
chemokines (e.g. CXCL8, CCL2), adhesion molecules
(CD54, CD62E, PECAM-1) and inflammatory factors
by endothelial cells via various mechanisms [20–22].
Paradoxically, in an attempt by the pathogen to sub-
vert the host immune response, the proteins of these
pro-inflammatory genes are degraded by Pg-derived
gingipains [20,23,24]. Adhesion molecules localised at
the cellular junctions of adjacent endothelial cells selec-
tively regulate vascular permeability [25]. Dysregulated
adhesion molecule expression may initiate vascular
pathology due to abnormally elevated vascular perme-
ability leading to oedema, chronic inflammatory and
vascular damage [26]. We recently showed that Pg can
cause vascular damage in an in vivo zebrafish larvae
model of systemic infection in a gingipain-dependent
manner [27], suggesting that these bacterial proteases
may be important factors in the development of CVD.
Here, we hypothesised that gingipain-dependent cleav-
age of endothelial cell junction adhesion molecules is
important in mediating the vascular damage. By
infecting transgenic zebrafish models that have fluores-
cent labelling of endothelial cell junctions with a wild-
type and isogenic gingipain-null Pg mutant, we iden-
tify that gingipains dramatically alter adhesion mole-
cule cell surface abundance leading to increased
vascular permeability in vitro and in vivo. These data
significantly enhance the growing evidence for the role
of oral bacteria in CVD and indicate a potential mech-
anism by which oral bacteria can contribute to cardio-
vascular disease.
Results
P. gingivalis invades human endothelial cells and
localises to the perinuclear region through a
gingipain-dependent mechanism
We initially confirmed Pg invasion of endothelial cells
using an antibiotic protection assay. All wild-type lab-
oratory strains examined (ATCC33277, W83, W50)
invaded HDMEC at significantly greater levels than
the clinical isolate (A245Br) (P ≤ 0.05, Fig. 1A). Wild-
type W83 was not only capable of invading various
types of endothelial cells including HDMEC
(0.072%  0.032; Fig. 1A,B), HMEC-1 (0.48%  0.2;
Fig. 1C) and HCAEC (0.21%  0.1; Fig. 1D), but
was also shown to be significantly more invasive than
the gingipain-deficient ΔK/R-ab mutant (P < 0.001)
that displayed on average an 85% reduction in
endothelial cell invasion for the three cell types tested
(Fig. 1B–D). Multichromatic confocal microscopy
revealed that intracellular dwelling Pg were predomi-
nantly localised to the perinuclear regions, where they
were colocalised within wheat germ agglutinin-positive
membranes, suggesting residence within membrane-
bound intracellular vesicles following internalisation,
as previously shown in other model systems (Fig. 1E).
Endothelial cell permeability increases following
Pg infection and is gingipain-dependent
We previously demonstrated that zebrafish systemically
infected with Pg displayed significant oedema [27], sug-
gesting that this bacterium may influence vascular per-
meability. To explore this possibility, we examined
HDMEC monolayer permeability following Pg infec-
tion in vitro. Microscopically, Pg-infected HDMEC
were found to lose cell–cell attachments compared
with uninfected controls (Fig. 2A). Using a high
molecular weight fluorescent dextran permeability
assay, we observed a time-dependent increase in the
levels of fluorescence passing through the endothelial
monolayer and this was significantly increased in Pg-
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treated compared with untreated HDMEC at all time
points examined for up to 5 h (Fig. 2B). Moreover,
this increase in endothelium permeability was signifi-
cantly reduced (P < 0.001) compared with untreated
control levels or when Pg W83 was pre-incubated with
KYT, a specific inhibitor of gingipain activity (Fig. 2
C) [28]. Similarly, endothelial permeability was also
significantly reduced (P < 0.001) when monolayers
were infected with the gingipain-deficient mutant ΔK/
R-ab compared with wild-type controls (Fig. 2D). Col-
lectively, these data implicate gingipains as the primary
permeabilising factor following Pg infection.
Pg infection decreases endothelial cell surface
adhesion molecule abundance but not gene
expression in vitro
The endothelial cell surface adhesion proteins PECAM-
1 (CD31) and VE-cadherin (CD144) are crucial for
maintaining cell–cell junction integrity and preserving a
restrictive endothelial permeability barrier [25,29].
Gingipains have been shown to mediate the proteolytic
degradation of several human proteins [20,30]; there-
fore, we examined whether these proteases were respon-
sible for cleavage of PECAM-1 and VE-cadherin. Flow
cytometric analysis revealed that cell surface abundance
of PECAM-1 on both HMEC-1 and HDMEC was
almost completely abolished upon W83 infection com-
pared with uninfected controls when analysed by both
flow cytometry (P < 0.05; Fig. 3A,C) and immunofluo-
rescence microscopy (Fig. 3E). In contrast, endothelial
cells infected with the gingipain-null mutant, ΔK/R-ab,
showed no loss of PECAM-1, displaying levels similar
to uninfected controls (Fig. 3A,C). Cell surface abun-
dance of VE-cadherin on both HMEC-1 and HDMEC
was reduced by sixfold upon infection with W83
(P ≤ 0.05; Fig. 3B,D). In contrast, cells infected with
ΔK/R-ab displayed VE-cadherin levels similar to those
of uninfected controls (Fig. 3B,D). Loss of VE-cadherin
was observed predominantly at the cell–cell junctions by
confocal microscopy, sites where this protein
Fig. 1. Strain and gingipain-dependent invasion of Pg into human
endothelial cells. HDMEC were infected with wild-type strain Pg
ATCC33277, W83, W50 or A245Br (A) or wild-type Pg W83 and
∆K/R-ab (B) at a MOI 100 for 90 min. HMEC-1 (C) and HCAEC (D)
were infected with wild-type Pg W83 or ∆K/R-ab mutant also at a
MOI 100 for 90 min. Bacterial cell invasion was determined by
antibiotic protection assay and expressed as a percentage of
primary bacterial inoculum recovered. Graphs show means  SD
(n = at least 3 individual experiments with each individual
experiment performed in triplicate technical repeats; shown as
filled circles). Data were analysed using one-way ANOVA with
Tukey’s post hoc comparison test (Fig. 1A) or Student’s t-test
(Fig 1B-D), *P < 0.05, **P < 0.01, ***P < 0.001. Representative
maximum intensity Z projection images of HMEC-1 with
intracellular (green) and extracellular (cyan) Pg W83. Cell nucleus
(blue) and plasma membrane (red). Composite image shows
intracellular dwelling Pg as orange (green and red colocalisation,
white arrow), and extracellular (cyan) bacteria bound to the cell
surface (E). All images show x-axis, y-axis and z-axis planes, and
scale bars in images are all 5 μm.
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preferentially accumulates (Fig. 3F). Loss of PECAM-1
adhesion molecule cell surface expression was MOI-de-
pendent (Fig. 4A) and not due to differences in endothe-
lial cell death upon infection as cell viability was similar
to controls following infection with either W83 or ΔK/
R-ab (Fig. 4B–E). In addition, reduced abundance of
the endothelial cell surface adhesion molecule, E-selectin
(CD62E), a protein that plays a role in leucocyte adhe-
sion rather than vascular permeability, was also
observed (Fig. 5). The levels of cell surface E-selectin
were increased on HDMEC at 4 and 8 h following treat-
ment with TNFα, whereas immortalised HMEC-1 cells
did not display E-selectin at any time point examined
irrespective of cytokine treatment (Fig. 5A–D). Pg was
able to invade both HDMEC and HMEC-1 at similar
levels in the absence or presence of pro-inflammatory
stimulation (Fig. 5E,F). In 8-h TNFα-treated HDMEC,
infection with Pg significantly (P < 0.001) reduced E-se-
lectin cell surface abundance by fivefold compared with
uninfected controls (Fig. 5G,H).
An alternative explanation for the loss of endothelial
cell surface adhesion molecule expression is that the
bacterial infection may reduce gene expression. To test
for this possibility, we checked for differences in
endothelial mRNA expression by qRT–PCR following
incubation with wild-type W83 and mutant ΔK/R-ab
Pg. Incubation with either of these strains did not sig-
nificantly alter gene expression of VE-cadherin,
PECAM-1 or other tested cytokines (CXCL8, CCL2,
ICAM-1) in HMEC-1 and HDMEC cultures when
compared to the treatment with the potent pro-inflam-
matory cytokine, TNFα (Fig. 6A,B).
P. gingivalis reduces endothelial cell surface
adhesion molecule abundance in an in vivo
zebrafish infection model
We next used our established Pg zebrafish infection
model [27] to determine whether the observed changes
in adhesion molecule cell surface abundance seen in
Fig. 2. Pg W83 increases permeability of endothelial cell monolayers in a gingipain-dependent manner. HDMEC (A–C) or HMEC-1 (D) cells
were grown to confluent monolayers on fibronectin-coated inserts, infected with Pg at a MOI 1000 for 1.5 h, followed by the measurement
of high molecular weight (70 kDa) fluorescein dextran passing through the monolayer barrier. Morphology of HDMEC monolayer in the
absence (−Pg) or presence (+Pg) of W83 (A); white arrows indicate areas of cell attachment loss (scale bar in A = 20 μm). In vitro
permeability assay of HDMEC in the absence (−Pg) or presence (+Pg) of W83 (B) and upon treatment with KYT inhibitors prior to HDMEC
Pg infection (C). In vitro permeability assay of HMEC-1 infected with W83 or ΔK/R-ab (D). Data in B&C are presented as means  SD and
were analysed by one-way ANOVA followed by Tukey’s post hoc comparison test. *P < 0.05, ***P < 0.001. Data in D are presented as
means  SD and were analysed by Student’s t-test. ***P < 0.001; for all experiments, n = 3 individual experiments with each individual
experiment performed in triplicate technical repeats.
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vitro were replicated in vivo. Transgenic zebrafish with
endothelial cell-specific PECAM-1-EGFP expression tg
(fli1a:PECAM1-EGFP)sh524 were inoculated systemi-
cally with either red-labelled wild-type W83 or ΔK/R-
ab Pg. Reporter fluorescence was quantified where the
endothelium and Pg colocalised in the intersegmental
vessels and the caudal vein adjacent to the yolk sac,
anatomical sites that are free from any natural pig-
mentation to avoid problems with background fluores-
cence and where individual vessels were easily
distinguished. In PBS-injected zebrafish, PCAM-1
expression was observed on the endothelial cell surface
of the intersegmental vessels as well as the caudal
artery and vein (Fig. 7A,D). Both W83 and ΔK/R-ab
gingipain-null bacteria could be visualised within the
vessels at these sites (Fig. 7B,E and C,F), binding to
and in some instances having traversed the vascular
barrier into surrounding tissue (Fig. 7Gii). Impor-
tantly, in W83-infected zebrafish, colocalisation of Pg
at the endothelial surface was associated with a
marked reduction in endothelial PECAM-1 fluores-
cence at these sites (Fig. 7Gi,Gii). Consistent with our
in vitro experiments, we observed that loss of
PECAM-1-EGFP fluorescence was gingipain-depen-
dent since infection with the gingipain-null mutant,
ΔK/R-ab, was not associated with loss of PECAM-1-
Fig. 3. Degradation of endothelial cell surface-expressed junctional adhesion molecules in vitro. Representative flow cytometry histograms
of cell surface expression of PECAM-1 (A) and VE-cadherin (B) on HMEC-1 and HDMEC following infection with Pg W83 (green) or ΔK/R-ab
mutant (blue); IgG control (red); and uninfected control (orange). Normalised median fluorescence intensity (nMFI) histograms of PECAM-1
(C) and VE-cadherin (D) on HMEC-1 and HDMEC following infection with Pg W83, ΔK/R-ab or uninfected control (enclosed circles represent
data from each individual experiment, n = 4). Statistical differences were analysed by one-way ANOVA with Tukey’s multiple comparison
test *P < 0.05, **P < 0.01, ***P < 0.001. Micrograph images show immunofluorescent detection of cell surface expression of PECAM-1
(red, E) and VE-cadherin (green, F) in control or Pg-treated HDMEC (n = 3). Nuclei were counterstained blue with DAPI. Scale bars in E &
F = 100 μm.
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EGFP fluorescence (Fig. 7Gi). Indeed, fluorescence
intensity analysis showed that PECAM-1 fluorescence
was significantly reduced in the presence of W83 com-
pared with ΔK/R-ab on both the intersegmental ves-
sels in the tail (Fig. 7H, P < 0.001) and caudal vein
(Fig. 7I, P < 0.01). We next employed fluorescently
tagged VE-cadherin-TS transgenic zebrafish larvae and
quantified transgene fluorescence following PBS, W83
or ΔK/R-ab infection (Fig. 8A–F). Similar to the effect
on PECAM1-EGFP, when colocalised with the vascu-
lature (Fig. 8B,Gi), wild-type Pg significantly reduced
the fluorescence intensity of the VE-cadherin-TS repor-
ter on both intersegmental (Fig. 8H, P < 0.01) and
caudal vein (Fig. 8I, P < 0.05) vessels when compared
to ΔK/R-ab mutants, suggesting reduced fluorescence
of this reporter fusion protein was also gingipain-de-
pendent.
Pg infection increases vascular permeability
in vivo
We next tested whether Pg infection could also lead to
increased vascular permeability in an in vivo setting.
Here, we used transgenic zebrafish expressing a cyan
fluorescent protein, mTurquiose2, in endothelial cells
(tg(fli1a:mTQ2)sh321), to fluorescently label the vas-
culature and injected these with either fluorescein-la-
belled Pg or PBS as control followed by further
injection with tetramethylrhodamine (a red fluorescent)
dextran at 24 hpi. In PBS-injected larvae, the fluores-
cent dextran strictly localised to the lumen of the aor-
tic arches, opercular artery, hypobranchial artery and
other vessels in the vascular network, indicating that
the high molecular weight dextran was not able to pass
across the vascular barrier (Fig. 9A,D). Following
infection, Pg was observed both within blood vessels,
their surrounding tissues and in particular around the
oedematous heart (Fig. 9B,E). In these infected larvae,
diffuse fluorescent dextran staining was observed
throughout tissues, extending far beyond the confines
of the aortic arches suggesting widespread dextran
leakage from vessels (Fig. 9C,F). Furthermore, dextran
fluorescence was observed in the oedematous pericar-
diac region suggesting widespread vessel leakage in this
area (Fig. 9C,F). These data, along with our in vitro
studies, provide compelling evidence that Pg is able to
mediate vascular damage leading to loss of endothelial
integrity and increased vascular permeability.
Discussion
Increasing evidence suggests that periodontal disease is
associated with CVD and that this is influenced, in
part, by bacteria that enter the circulation via diseased
tissues in the oral cavity [1,6]. Further supporting evi-
dence comes from in vitro studies showing that oral
microbes, in particular Pg, can invade endothelial cells,
but more compellingly from human studies where the
DNA of several oral bacteria, including Pg, has been
found in nondiseased vascular tissue from patients
undergoing bypass surgery [16] as well as in atheroscle-
rotic plaques [31–33]. However, the molecular
Fig. 4. Pg-mediated decrease in PECAM-1 cell surface abundance
is MOI-dependent on viable endothelial cells. (A) PECAM-1 cell
surface abundance on HMEC-1 cells as determined by flow
cytometric analysis following infection with increasing MOI of Pg;
uninfected cells were used as controls (enclosed circles represent
data from each individual experiment). Data are displayed as
normalised median fluorescence intensity (nMFI), and statistical
differences were analysed by one-way ANOVA with Tukey’s
multiple comparison test; *P < 0.05, **P < 0.01 compared with
MOI 0, 1, 10. HMEC-1 (B&C) and HDMEC (C&D) viability
postinfection as assessed by a live/dead TO-PRO-3 exclusion flow
cytometric assay. The level of per cent viable cells (TO-PRO-3-
negative, blue dots) in the cell population was measured for W83
and ΔK/R-ab-treated cells. One-way ANOVA with Tukey’s multiple
comparison test showed no statistically significant differences in
cell survival between groups following infection.
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mechanism driving this association is, as yet,
unknown, with several divided theories proposed on
how this relationship develops. Therefore, in this study
we used both in vitro and in vivo approaches to deci-
pher the mechanisms at play with particular emphasis
on the role of gingipains, potent proteases known to
play a key role in Pg-mediated disease processes [34].
Our initial in vitro studies using monolayers of
endothelial cells from various vascular beds showed
that Pg (strains ATCC33277, W83, W50, A245Br)
were invasive but at low levels (~ 0.1%), which is in
agreement with previous findings from other groups
[18,19,35,36]. Collectively, these data show that
endothelial cells are less susceptible to invasion than
Fig. 5. Pg W83 infection decreases E-
selectin abundance on HDMEC in vitro. Cell
surface abundance of E-selectin increased
in a time-dependent manner on HDMEC (A)
upon treatment with TNFα (10 ngmL−1)
when analysed by cell-based ELISA.
Expression increased at 4 h, displayed
maximal expression after 8 h (P < 0.05,
Mann–Whitney U-test, n = 3) with levels
returning to baseline by 24 h. HMEC-1 cells
did not express E-selectin at any time point
examined (B). These data were confirmed
by flow cytometric analysis where E-
selectin abundance was increased on
HDMEC after 8 h TNFα stimulation (C) but
was not present on HMEC-1 with levels
being similar to unstimulated controls (D).
Whisker plots showing that stimulation of
HDMEC (E) or HMEC-1 (F) with 10 ngmL−1
TNFα for 8 h did not result in increased
invasion of Pg W83 compared with
unstimulated control cells (enclosed squares
and circles denote number of experiments
performed, and data are mean  SD).
Representative flow cytometry histogram of
cell surface expression of E-selectin (G) on
8 h TNFα-stimulated HDMEC following
infection with Pg W83 (orange), IgG control
(red) and uninfected control (blue). E-
selectin normalised median fluorescence
intensity (nMFI) histograms of Pg W83-
infected and Pg W83-uninfected controls.
Statistical differences in E, F and H were
analysed by Mann–Whitney U-test of n = 3
independent experiments, ***P < 0.001.
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oral epithelial keratinocytes that can display from 2%
to 10% cell invasion depending on the strain examined
[37,38]. Moreover, the gingipain-null mutant ΔK/R-ab
failed to invade endothelial cells, suggesting that bacte-
rial gingipains are crucial for this process. Confocal
microscopy analysis confirmed the presence of intracel-
lular dwelling Pg enclosed within membrane-bound
vesicles at perinuclear sites in endothelial cells, similar
to that documented for gingival epithelial cells, most
likely as a result of endocytosis [19,39,40]. Internalisa-
tion has several beneficial outcomes for the bacterium
including protection from the host immune response,
resistance to antibiotic therapy (many cannot pass the
plasma membrane) and increased survival [39]. When
infected with wild-type Pg, HDMEC within confluent
monolayers became detached and the endothelium dis-
played significant loss of permeability in vitro that was
prevented by inhibition of gingipain enzyme activity or
upon infection with ΔK/R-ab, the gingipain-null
strain. Similar observations were reported by Sheets
et al. [24] who noted that bovine coronary artery
endothelial cells and HDMEC exhibited loss of adhe-
sion to tissue culture plastic upon culture with Pg-
derived culture extracts. These data clearly point to
proteolytic degradation of cell surface molecules as the
likely mechanism for loss of cell–cell contacts and
adhesion. Indeed, our flow cytometric and confocal
microscopy analysis revealed gingipain-dependent
cleavage of PECAM-1, VE-cadherin and E-selectin
(CD62E) on human endothelial cells when cultured as
monolayers in vitro.
E-selectin is an adhesion molecule associated with
tethering of leucocytes to the endothelium during
inflammation. It was previously shown that Pg adhe-
sion to human umbilical vein endothelial cells
(HUVEC) that are derived from large blood vessels is
mediated by E-selectin [24,41]. In contrast, our data
indicate that Pg adhere and invade both E-selectin-de-
ficient HMEC-1 and E-selectin-expressing HDMEC at
similar levels, suggesting that E-selectin is not essential
for invasion into microvascular endothelial cells.
Gingipain-dependent degradation of other leucocyte
adhesion molecules (ICAM-1/CD54, VACM-1/CD106)
has also been observed [30], suggesting that Pg is able
to modulate leucocyte recruitment at the endothelium
surface. PECAM-1 and VE-cadherin act to form inter-
cellular junctions that are crucial for maintaining a
continuous endothelium and so loss of these cell–cell
contacts will inevitably lead to loss of tissue integrity,
increased permeability and endothelial dysfunction. In
this study, loss of PECAM-1 and VE-cadherin cell sur-
face abundance was identified in response to whole
bacteria, whereas previous studies have used recombi-
nant gingipains to show cleavage of endothelial cell
surface proteins including N-cadherin and integrin β1
as well as VE-cadherin [24]. Gene expression analysis
Fig. 6. Infection of endothelial cells with Pg
W83 or ΔK/R-ab does not alter mRNA
expression of pro-inflammatory genes.
HMEC-1 (A) and HDMEC (B) cells were
infected with either W83 or ΔK/R-ab (MOI
100) for 4 h, unstimulated or TNFα-
stimulated (25 ngmL−1) cells were used as
controls. Bars represent means  SD of
relative fold change expression of VE-
cadherin, PECAM-1, CXCL8, CCL2 and
ICAM-1. Data were analysed by
Kruskal–Wallis with Dunn’s multiple
comparison test; **P ≤ 0.01, n = 3
individual biological experiments each
performed in triplicate technical repeats.
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showed no change in expression levels of PECAM-1 or
VE-cadherin as well as other inflammatory cytokines
(CCL2, CXCL8 and ICAM-1) in response to infection
with either wild-type W83 or ΔK/R-ab Pg, confirming
that loss of cell surface protein was due to protein
cleavage and not altered gene transcription. Interest-
ingly, our gene expression data are in contrast to those
reported by others who have observed increased gene
expression for CCL2 (formally MCP-1) by HUVEC in
response to Pg strain 381 [42] and ICAM-1 by
E.A.hy926 cells (an endothelial/epithelial hybrid cell
line) or HUVEC upon infection with Pg strain
ATCC33277 or W83, respectively [43,44], which may
be due to bacterial strain differences or to use of cell
lines or endothelial cells derived from large compared
with microvascular vessels.
In vitro generated data using monolayer endothe-
lium provide valuable information, but these experi-
ments lack conditions such as flow, shear stress and
presence of other cells that are important when exam-
ining systemic infection. We therefore set about con-
firming the in vitro data using our zebrafish Pg
infection model [27]. Zebrafish have been extensively
used for host–pathogen interactions as well as for car-
diovascular studies [45] and have several advantages
over murine models such as transparency and avail-
ability of fluorescently tagged proteins that allow for
real-time analysis of cell–cell interactions. Moreover,
A B C
D E F
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Fig. 7. PECAM-1 expression in an in vivo
zebrafish embryo systemic infection model.
Representative images of spinning disc
confocal micrographs showing PECAM-1
expression (green) in the tail region (A–C)
and yolk region (D–F) of zebrafish embryos
at 24 hpi. Embryos were injected with PBS
control (A&D), wild-type W83 Pg (red, B&E)
or ΔK/R-ab mutant (red, C, F) n = 15.
Decreased fluorescence in W83 expression
was observed in infected segmental
vessels, while loss of definition in W83-
infected vessels is clearer than in caudal
vein and artery. Loss of PECAM-1
expression is exemplified in high-
magnification images of the caudal vein
showing PBS controls (Gi, top), W83-
infected (Gi, middle) and ΔK/R-ab-infected
(Gi, lower) embryos and in the
intersegmental vessels which show a
marked loss of PECAM-1 fluorescence
(green) when colocalised with red-labelled
W83 (Gii, circled areas). W83 can also be
observed in the tissues having traversed
the vasculature (Gii, white arrows). Image
analysis showed significantly decreased
normalised median fluorescence values and
therefore PECAM-1 expression in both the
tail (H) and caudal vein (I) between zebrafish
embryo infected with W83 and ΔK/R-ab Pg
(**P < 0.01, ***P < 0.001, Student’s t-test;
data are means  SD of 3 pooled
independent biological experiments (n = 3)
with 5 technical repeats per experiment).
CA, caudal artery; CV, caudal vein; DLAV,
dorsal longitudinal anastomotic vessel; Se,
intersegmental vessels; Y, yolk sac. Scale
bar A–G = 40 µm.
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the close homology between numerous zebrafish and
human innate immune and cardiovascular-associated
molecules means that this in vivo model system is also
ideally placed to examine pathogen-mediated host
responses that may impact on CVD risk. We previ-
ously showed that zebrafish present with oedema upon
infection with wild-type but not the ΔK/R-ab gingi-
pain-null mutant [27] and given our in vitro data on
gingipain-dependent endothelial cell adhesion molecule
degradation we hypothesised that gingipains would be
responsible for cleavage of these molecules in vivo lead-
ing to vascular permeability. Using genetically engi-
neered zebrafish whereby PECAM-1 or VE-cadherin
was fluorescently labelled, we observed, for the first
time, in vivo Pg-mediated loss of fluorescence upon
infection with wild-type (W83) but not with the gingi-
pain-null mutant strain, indicating gingipain-dependent
degradation of these molecules. Loss of PECAM-1
and VE-cadherin on the endothelium was most evident
when colocalised with W83 Pg and was apparent in
several vascular regions of the zebrafish indicating that
infection is widespread and that Pg adhesion and
gingipain-mediated protein degradation are not con-
fined to specific vascular beds. Even more important
was that loss of adhesion molecule abundance was
associated with increased vascular permeability as
A B C
D E F
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Fig. 8. VE-cadherin (CDH5) expression in an
in vivo zebrafish embryo systemic infection
model. Representative images of spinning
disc confocal micrographs showing VE-
cadherin expression (green) in the tail
region (A–C) and yolk region (D–F) of
zebrafish embryos at 24 hpi. Embryos were
injected with PBS control (A, D), wild-type
W83 Pg (red, B, E) or ΔK/R-ab mutant (red,
C, F) n = 12. Decreased VE-cadherin
fluorescence when colocalised with W83
was observed in infected segmental
vessels and caudal vein. The loss of VE-
cadherin expression is exemplified in high-
magnification images from A, B and C
showing PBS controls (Gi, left), W83-
infected (Gi, middle) and ΔK/R-ab-infected
(Gi, right) intersegmental vessels. Image
analysis showed significantly decreased
normalised median fluorescence values and
therefore VE-cadherin expression in both
the tail (G) and caudal vein (H) between
zebrafish embryo infected with W83 and
ΔK/R-ab mutant Pg (*P < 0.05, **P < 0.01,
Student’s t-test, and data are means  SD
of 3 pooled independent biological
experiments (n = 3) with 4 technical
repeats per experiment). CA, caudal artery;
CV, caudal vein; DLAV, dorsal longitudinal
anastomotic vessel; Se, intersegmental
vessels; Y, yolk sac. Scale bar A-G =
40 µm.
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determined by dextran vascular leakage, signifying loss
of endothelium integrity and vascular damage, both
implicated in the pathogenesis of cardiovascular dis-
ease [46].
Several in vivo studies using murine experimental
models, in particular the hyperlipidaemic ApoE(null)
mice, have shown that Pg infection directly influences
atherosclerotic lesion formation or development [47,48]
and several mechanisms have been suggested. How-
ever, visualising bacterial–host interactions at a cellular
and even protein level are not possible in these models.
To our knowledge, this is the first time that the effects
of systemic Pg infection at the cellular level, in vivo,
have been reported and our data clearly point to a role
for Pg in mediating vascular damage. At present, it is
unknown whether Pg acts as an initiating event, where
it could be speculated that Pg-mediated endothelial
cell damage leads to the exposure of the underlying
vascular connective tissue leading to localised platelet
activation and leucocyte recruitment. However, it
could also be speculated that Pg acts to exacerbate the
disease process by negatively modulating the immune
response. Clearly, further studies are warranted to
decipher the precise role of Pg in CVD.
As with most in vivo experimental infection models,
animals (mice or zebrafish) are systemically inoculated
with high numbers of bacteria, much more than would
be observed in humans, and it could be argued that
these studies are therefore not completely physiologi-
cally relevant. However, it should be noted that many
cardiovascular diseases are long-term, chronic condi-
tions where the disease manifests over long periods
with repeat exposure to transient levels of one if not
several aetiological agents. Replicating this experimen-
tally in vivo is extremely challenging and would require
repeat low-dose inoculation or a long time frame, giv-
ing raise to ethical concerns over animal distress as
well as experimental cost. Current, in vivo infection
strategies aim to provide key information that collec-
tively points to significant risk factors within the full
knowledge of their limitations. In this regard, zebrafish
provide clear benefits as an in vivo model to examine
systemic host–pathogen interactions, and our data sig-
nificantly add to others in implicating Pg in vascular
pathogenicity. There is now an appreciation that many
bacterial-mediated diseases are polymicrobial in nat-
ure, with periodontitis being a case in point where it is
considered that several organisms within the subgingi-
val plaque drive pathogenesis rather than one organ-
ism in isolation. It is therefore likely that other oral
bacteria contribute to systemic disease. Indeed, in the
oral context, studies have shown significant impacts on
A B C
D E F
Fig. 9. Pg W83 infection increases vascular permeability in zebrafish embryos. Representative maximum intensity Z projection
microangiography of PBS-injected (A, D) or fluorescein-stained wild-type W83 Pg-infected (green, B, C, E, F) zebrafish embryos with cyan-
labelled vasculature before (B, E) and after red fluorescent dextran injection (A, C). Upper panels show ventral view and lower panels lateral
view. White arrows in panels B&E indicate W83 within blood vessels, tissues and oedematous heart. Dashed lines in A, C, D and F outline
the aortic arches (AA) and opercular artery (ORA) vascular regions. Yellow arrows in C and F point to regions demonstrating dextran leakage
from the vasculature into the tissues. Data are representative of n = 3 independent biological experiments. HA, hypobranchial artery; PE,
pericardial oedema. Scale bar = 100 µm.
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the functional behaviour of Pg when in the presence
of other oral microbes such as Tannerella forsythia or
Fusobacterium nucleatum [49] and it will be important
to determine whether other microbes affect disease
progression. Nevertheless, this study provides crucial
evidence for the role of Pg, and gingipains in particu-
lar, in affecting endothelial function, reaffirming the
likely role or oral microbes in influencing systemic dis-
ease outcomes.
Materials and methods
P. gingivalis strains and culture
Wild-type strains W50, ATCC33277 and W83, as well as
clinical strain A245Br, were maintained on Fastidious
Anaerobe (FA) agar plates (NeoGen, Ayr, UK) supple-
mented with 5% v/v oxalated horse blood (Oxoid, Bas-
ingstoke, UK). Isogenic gingipain-deficient mutant
kgpΔ598-1732::TcR rgpA-::CmR rgpBΔ410-507::EmR (ΔK/
R-ab) was grown on blood FA plates supplemented with
1 μgmL−1 tetracycline and 5 μgmL−1 erythromycin. Liquid
cultures were maintained in either Schaedler (BTL Ltd.,
èo´dz´, Poland) or brain–heart infusion broth (Oxoid) sup-
plemented with 0.5 % yeast extract, 250 μgmL−1 cysteine,
1 mgmL−1 haemin and 1 mgmL−1 vitamin K (Oxoid).
Both liquid and agar cultures were incubated at 37 °C in
an anaerobic chamber with an atmosphere of 80% N2,
10% CO2 and 10% H2. For use in experiments, strains
were grown as liquid cultures anaerobically overnight,
adjusted to an optical density (OD600) equal to 0.1 and cul-
tured until late log phase. Bacteria were then harvested by
centrifugation at 8000 g for 3 min, washed with PBS and
resuspended at the required density. For zebrafish experi-
ments, bacteria were resuspended in PBS at
5 × 109 CFUmL−1 for microinjection.
Endothelial cell culture
Human primary coronary artery endothelial cells (HCAEC,
purchased from the American Tissue Culture Collection)
and human primary microvascular endothelial cells
(HDMEC, purchased from PromoCell, Heidelberg, Ger-
many) were maintained in MV medium containing MV
supplement medium (PromoCell®), while immortalised
human dermal microvascular endothelial cells (HMEC-1
provided by F.J. Candal, Centers for Disease Control and
Prevention, Atlanta, GA) were grown in MCDB131 (Fisher
Scientific, Loughborough, UK) supplemented with
10 ngmL−1 epidermal growth factor (Sigma-Aldrich, Poole,
UK), 1 µgmL−1 hydrocortisone (Sigma), 10% v/v fetal calf
serum (Thermo Fisher Scientific, Loughborough, UK) and
2 mM L-glutamine (Sigma-Aldrich). All cells were cultured
at 37 °C, 5% CO2 in a humidified atmosphere.
Animals
Zebrafish maintenance and experimental work were carried
out in accordance with UK Home Office regulations and
UK Animals (Scientific Procedures) Act 1986 and EU
directive 2010/63/EU under Project Licence P1A4A7A5E
using zebrafish embryos under 5 days postfertilisation
(dpf). Nacre wild-type, VE-cadherin transgenic tg(cdh5ubs8−/
−;cdh5TS), PECAM-1 transgenic tg(fli1a:PECAM1-
EGFP)sh524 and tg(fli1a:mTurquoise2)sh321 embryos were
maintained in E3 medium at 30 °C according to standard
protocols. Anaesthesia of zebrafish larvae was achieved by
adding 0.16 mgmL−1 tricaine (Sigma-Aldrich) to E3 med-
ium, while addition of 0.3 mgmL−1 tricaine was used for
euthanasia.
Generation of zebrafish transgenic lines
Tg(fli1a:PECAM1-EGFP)sh524 was generated via injection
of pTol2-fli1a-pecam1-EGFP according to standard proto-
cols. Tg(fli1a:mTurquoise2)sh321 was generated by PCR
amplifying the coding sequence of mTurquoise2 from
pmTQ21-C1, a kind gift of Joachim Goedhart (University
of Amsterdam), using the following primers 50-ggccggatc-
catggtgagcaagggcgag-3, 50-ggccctcgagttacttgtacagctcgtc0-30
and cloning into the BamHI/XhoI sites of pME-MCS2 [50]
to generate pME-mTurquoise2. The pFli1a:mTurquoise2-
SV40pA construct was generated using the Tol2kit via
standard methods and the following components: fli1a
enhancer/promoter, pDestTol2-pA2, pME-mTurquoise2
and p3E-SV40pA, and injected into embryos alongside
Tol2 mRNA at 25 pgnL−1.
Endothelial cell invasion quantification and
visualisation
Antibiotic protection endothelial cell invasion assays were
performed as described in Naylor et al. [51], with modifica-
tion. HCAEC, HDMEC or HMEC-1 cells were seeded at
2 × 105 cells per well in a 24-well plate and cultured to con-
fluence. Cell monolayers were washed with PBS and
blocked for 1 h with 2% bovine serum albumin (BSA;
Sigma-Aldrich) in cell culture medium. Endothelial cells
were infected with Pg strains (ATCC33277, W83, W50 or
A245Br) at a multiplicity of infection (MOI) of 100 in cell
culture medium and incubated for 90 min at 37 °C, 5%
CO2. Serial dilutions were carried out to determine viable
counts through colony-forming units (CFUs). Nonadhered
bacteria were removed with PBS and the cell-adherent bac-
teria killed by incubation with 200 μgmL−1 metronidazole
(Sigma-Aldrich) for 1 h at 37 °C, 5 % CO2. Cells were then
washed with PBS, lysed with dH2O, scraped, serially
diluted on FA plates and incubated anaerobically for
3 days. CFUs were enumerated to determine the total
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number of invading bacteria, expressed as a percentage of
the viable count of the initial inoculum.
To visualise Pg invasion, HMEC-1 cells were grown
overnight on 4-well glass-bottom culture chambers (Sarst-
edt AG, Nu¨mbrecht, Germany). Pg W83 was fluorescently
labelled by re-suspension in 0.4 μgmL−1 5-(and-6)-car-
boxyfluorescein, succinimidyl ester (5(6)-FAM, SE) (excita-
tion 494 nm, emission 518 nm) (Thermo Fisher Scientific)
in PBS for 15 min with shaking at 4 °C. FAM-labelled Pg
were further biotinylated by diluted in 0.3 mgmL−1 6-((bi-
otinoyl)amino)hexanoic acid, succinimidyl ester (Thermo
Fisher Scientific) in PBS and incubated for 30 min and then
resuspended in nonsupplemented MCDB medium. FAM-
biotinylated Pg were used for invasion (MOI 1000) into
HMEC-1 cells for 1 h at 37 °C, 5% CO2. HMEC-1 cells
were fixed with 4% paraformaldehyde (Sigma-Aldrich) for
20 min, washed and blocked with 10% v/v FCS in PBS for
5 min. Alexa Fluor 647
®-conjugated streptavidin (excitation 650 nm,
emission 655 nm) (Thermo Fisher Scientific) 5 μgmL−1 in PBS contain-
ing 10% v/v FCS was incubated with the cells for 45 min
at 37 °C, 5% CO2. After washing, nuclei were counter-
stained with 7.5 μgmL−1 Hoechst® (excitation 350 nm,
emission 461 nm) (Thermo Fisher Scientific) for 10 min,
rinsed and the endothelial plasma membrane stained with
5 μgmL−1 wheat germ agglutinin (WGA) (excitation
555 nm, emission 565 nm) (Thermo Fisher Scientific) for
10 min at 37 °C. Chamber slides were analysed using a
Zeiss LSM 880 inverted Axio Imager and AiryScan confo-
cal microscope. Images were processed using AiryScan®
processing (Zeiss, Oberkochen, Germany), and composite
and orthogonal views were created using FIJI® software
(National Institute of Health, Bethesda, MD, USA).
Endothelial cell permeability
Endothelial monolayer permeability was measured using a
Transwell assay system. Millicell® cell culture inserts
(Merck Millipore, Watford, UK) were fibronectin-coated
(10 μgmL−1) prior to seeding with HDMEC that were cul-
tured until confluent. Pg W83 were treated with KYT-1 or
KYT-36 (2 μM; Peptides International, Louisville, KY,
USA) to inhibit gingipain activity as previously described
[28]. HDMEC were infected in the absence or presence of
Pg W83 (with or without inhibitors) at a MOI of 1000 for
1.5 h at 37 °C in nonsupplemented MV medium. Bacteria
were removed, inserts transferred to a new 12-well plate
with 500 μL supplemented MV medium and 450 μL of MV
supplemented medium added to the apical compartment of
the insert together with 70 kDa fluorescent-labelled dex-
tran, a molecular weight that does not readily pass through
a confluent endothelial monolayer (Thermo Fisher Scien-
tific; final concentration of 65 μgmL−1). Dextran leakage
through the cell monolayer from apical compartment of the
insert to the bottom well was monitored for up to 5 h by
measuring the fluorescence intensity (excitation 494 nm,
emission 521 nm; Tecan Ltd, Ma¨nnedorf, Switzerland) of
250 μL medium aspirated from the bottom well; 250 μL of
fresh medium was added to the bottom well for further
readings. Inserts without cells were used as control wells.
In vitro PECAM-1 and VE-cadherin cell adhesion
protein expression
In vitro cell adhesion protein expression was analysed using
flow cytometry and immunofluorescence microscopy. For
flow cytometric analysis, HMEC-1 and HDMEC were
seeded at 4 × 105 cells per well, cultured until confluent,
rinsed and infected with MOI 1000 W83 or ΔK/R-ab Pg in
nonsupplemented medium for 1 h. Addition of medium
only was used as a control. Cells were washed, removed
using 0.02% EDTA (Sigma-Aldrich) for 20 min, cen-
trifuged and resuspended in 100 μL FACS buffer (0.1 %
BSA and 0.1 % sodium azide in PBS). For PECAM-1
(CD31) expression, 0.06 µg per test of PE-Cyanine7-conju-
gated anti-human PECAM-1 (Clone MW59; Thermo
Fisher Scientific) or its matching conjugated IgG control
(IgG2254 Isotype Control; Thermo Fisher Scientific) was
added and cells incubated for 45 min on ice. For VE-cad-
herin (CD144), 0.25 μg per reaction anti-human VE-cad-
herin antibody (Clone 123413, R&D Systems, Minneapolis,
MN, USA) or IgG isotype control (Clone 11711, R&D
Systems) was incubated for 45 min on ice, supernatant was
removed and Alexa Fluor® 488 goat anti-mouse antiserum
(Abcam, Cambridge, UK) diluted at 1 : 100 in FACS buf-
fer was added for 30 min on ice. Cells were washed and
resuspended in 300 μL FACS buffer, and single-colour
sample analysis was carried out using a LSR II flow
cytometer (BD Biosciences, San Jose, CA, USA) for PE-
CAM1 and FACSCalibur flow cytometer (BD Biosciences)
for VE-cadherin analysis. The cell viability dye, TO-PRO-
3® (1 mgmL−1, Thermo Fisher Scientific), was added to
each sample before analysis. Cell populations were gated
using forward scatter (FSC) and side scatter (SSC) voltages
and TO-PRO-3-positive cells excluded from the analysed
population. Five thousand viable cells were collected for
HDMEC analysis, while 10 000 live cells were collected for
HMEC-1 analysis. Threshold for positively fluorescent cells
was set using isotype-matched controls, and data were anal-
ysed using FlowJo software (BD Biosciences). The nor-
malised median fluorescence index (nMFI) was calculated
by dividing the median fluorescence intensity of the positive
samples by that of the IgG controls.
For immunofluorescence microscopy, fibronectin-coated
(10 μgmL−1) glass coverslips were seeded with 5 × 104
endothelial cells. Pg was stained with 5 μM Red CMTPX
CellTracker® (Thermo Fisher Scientific) and diluted to an
MOI 1000 in nonsupplemented cell culture medium to
infect primary and immortalised endothelial cells. Cells
were washed with PBS, fixed in 3.7% formalin for 10 min
at room temperature, washed again and blocked for 1 h
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with blocking buffer (2% BSA, 5% goat serum v/v in
PBS). For VE-cadherin staining, the cells were incubated
overnight at 4 °C with 3 μgmL−1 mouse anti-human VE-
cadherin (Clone # 123413, R&D Systems) in blocking buf-
fer, or with mouse IgG1 isotype control (Clone P3.6.2.8.1,
R&D Systems) at the same concentration. Following incu-
bation, slides were washed with PBS and incubated with
1 μgmL−1 Alexa Fluor 488 goat anti-mouse IgG (H + L)
secondary antibody for 1 h. Cells were rinsed again,
mounted in ProLong™ Diamond Antifade Mountant con-
taining 4’,6-diaminidine-2’-phylindole dihydrochloride
(DAPI) (Thermo Fisher Scientific) and imaged using a
Zeiss Axiovert 200M inverted fluorescence microscope with
an integrated high-resolution digital camera (AxioCam
MRm; Zeiss) with AxioVision 4.6 software (Zeiss). For
PECAM-1 staining, cells were blocked with 2.5% BSA in
PBS for 40 min and fixed in 2% paraformaldehyde for
20 min at room temperature. Cells were then washed in
PBS and stained with PE-Cy7 conjugated anti-human
PECAM-1 antibody (Clone WM59, BD Biosciences) for
40 min at room temperature. Nuclei were stained for 5 min
with 5 μgmL−1 DAPI (Sigma-Aldrich), washed, mounted
ProLong Diamond Antifade Mountant (Thermo Fisher Sci-
entific) and left to set overnight. Images were captured
using a Nikon A1 confocal microscope.
In vitro gene expression analysis
Quantitative reverse transcription polymerase chain reac-
tion (qRT–PCR) was used to analyse mRNA expression of
endothelial immune molecules. HMEC-1 and HDMEC
were seeded at 4 × 105 cells per well and cultured until con-
fluent. Cells were either infected with P. gingivalis W83 or
ΔK/R-ab mutant at a MOI 100 for 4 h, and unstimulated
or TNFα-stimulated (25 ngmL−1) cells were used as con-
trols. Total RNA extraction was carried out using ISO-
LATE II RNA Mini Kit (Bioline, Meridian Bioscience
Inc., Cincinnati, OH, USA) according to the manufac-
turer’s instructions and RNA measured by NanoDrop
(Thermo Fisher Scientific). High-Capacity cDNA Reverse
Transcription Kit (Thermo Fisher Scientific) was used to
produce cDNA and qPCR performed using Qiagen Rotor-
Gene (Qiagen, Hilden, Germany). Reactions consisted of
5 μL of TaqMan® qPCR BioProbe Blue Master Mix (PCR
Biosystems, London, UK), 3.5 μL RNase-free water,
0.5 μL human β-2-microglobulin (B2M) as an endogenous
reference control (VIC/MGB Probe, Thermo Fisher Scien-
tific), 0.5 μL target primer and 0.5 μL cDNA. Target pri-
mers used were PECAM-1 (Hs01065279_m1), VE-cadherin
(Hs00901465_m1), CXCL8 (Hs00174103_m1), CCL2
(Hs00234140_m1) and ICAM-1 (Hs0014932_m1) (Thermo
Fisher Scientific). All samples were run in triplicate; control
samples excluded cDNA. The threshold cycle (Ct) for each
test gene was normalised against their respective reference
controls. Fold change in expression relative to unstimulated
cells was calculated with ΔCt values of the sample and ref-
erence gene using the formula 2ΔΔCt .
In vivo PECAM-1 and VE-cadherin cell adhesion
protein expression
Tg(fli1a:PECAM1-EGFP)sh524 and Tg(cdh5ubs8-/-;cd-
h5TS) transgenic zebrafish were outcrossed with nacre zeb-
rafish. Embryos were dechorionated and green fluorescent
protein (GFP)-positive embryos selected at 1 dpf using a
fluorescent dissecting microscope (Zeiss Axio Zoom.V16 fit-
ted with an HXP 200C Illuminator and a Zeiss Axiocam
503 monocamera). Zebrafish embryos at 30 hpf were anaes-
thetised using tricaine (0.02% (w/v) 3-amino benzoic acid
ester tricaine/MS-322 (Sigma-Aldrich), positioned in a solu-
tion of 3% (w/v) methylcellulose (Sigma-Aldrich) in E3
medium and 2 nL (5 × 104 CFU) of 5 μM Red CMPTX
(CellTrackerTM, Thermo Fisher Scientific) stained W83 or
ΔK/R-ab Pg were injected systemically using a microcapil-
lary needle (Scientific Laboratory Supplies) via direct
microinjection into the Duct of Cuvier (the common cardi-
nal vein); PBS was used as control. Live imaging of anaes-
thetised fish (5 zebrafish embryos per group) was carried
out 24 h postinfection (hpi) using a spinning disc confocal
microscope (PerkinElmer UltraVIEW VoX, PerkinElmer
Inc., Waltham, MA, USA) running on an inverted Olym-
pus IX81 motorised microscope. 488-nm and 561-nm lasers
were used to visualise fluorescent PECAM-1 or CDH5/VE-
cadherin (green) and Pg bacteria (red) in zebrafish
embryos. Micrographs were captured in two areas of the
tail, adjacent to the cloaca (closer to the yolk) and 4 vessels
further away from the cloaca (closer to the tip of the tail)
using Volocity® software (Quorum Technologies Inc., Pus-
linch, Ontario, Canada). Quantification of relative GFP flu-
orescence intensity (pixel value) was performed by batch
processing of maximum intensity z projection of micro-
graphs of whole images in the yolk and tail region using an
adjusted script on FIJI® Macros plug-in.
In vivo vascular permeability
Zebrafish Tg(fli1a:mTurquoise2)sh321 embryos were
infected at 2 dpf with FAM-labelled Pg W83, ΔK/R-ab or
PBS as a control, into the common cardinal vein. Embryos
with a functional circulation at 24 hpi were anaesthetised
and injected into the posterior cardinal vein (PCV) with
2 nL of 1 mgmL−1 tetramethylrhodamine dextran
(2 × 106 kDa, Thermo Fisher Scientific). Microangiogram
images were acquired within an hour postdextran injection.
Real-time changes in vascular integrity were measured in
response to Pg W83 infection using light sheet microscopy
(Z1, Zeiss) with lasers 445-24, 488-30 and 561-20 with LSB
445/514/640.
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Statistical analysis
All data presented are from at least 3 independent experi-
ments (unless specified). Results are expressed as the
mean  standard deviation (SD) except for flow cytometry
data where the nMFI (normalised median fluorescence
index) was used. Normality was determined using Kol-
mogorov–Smirnov analysis. The differences between two
groups were assessed using either Student’s t-test or
Mann–Whitney U-test, while the differences between group
data were assessed using one-way ANOVA followed by
either Tukey’s or Dunn’s post hoc multiple comparison test
depending on the nature of the data (parametric or non-
parametric). All tests were carried out using GraphPad
Prism v8.2 (GraphPad, San Diego, CA, USA), and statisti-
cal significance was assumed at P < 0.05.
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